Elevance Health (NYSE:ELV) Earns “Overweight” Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research note released on Wednesday morning,Benzinga reports. The firm currently has a $485.00 price target on the stock. Cantor Fitzgerald also issued estimates for Elevance Health’s FY2025 earnings at $34.47 EPS. Several other equities analysts have also recently […]

Leave a Reply

Your email address will not be published.

Previous post Elevance Health’s (ELV) Outperform Rating Reiterated at Royal Bank of Canada
Next post Interested in remote work? The National Park Service may have a job for you